Suppr超能文献

拉莫三嗪用于治疗双相情感障碍。

Lamotrigine for the treatment of bipolar disorder.

作者信息

Engle P M, Heck A M

机构信息

Purdue University, West Lafayette, IN, USA.

出版信息

Ann Pharmacother. 2000 Feb;34(2):258-62. doi: 10.1345/aph.19128.

Abstract

OBJECTIVE

To describe the available data regarding the clinical efficacy of lamotrigine for the treatment of bipolar disorder.

SUMMARY

Anticonvulsants have emerged as alternative mood-stabilizing agents for patients with bipolar disorder who do not respond to lithium. Data regarding the efficacy of lamotrigine have been generated primarily from case reports, small open trials, and one large, randomized, placebo-controlled trial. These reports suggest that lamotrigine may be effective for the management of bipolar disorder.

CONCLUSIONS

Although current data are limited, treatment-refractory patients with bipolar disorder may benefit from lamotrigine therapy. Several studies are currently underway to determine the appropriate role of lamotrigine in the treatment of bipolar disorder.

摘要

目的

描述有关拉莫三嗪治疗双相情感障碍临床疗效的现有数据。

总结

对于对锂盐无反应的双相情感障碍患者,抗惊厥药已成为替代的心境稳定剂。有关拉莫三嗪疗效的数据主要来自病例报告、小型开放试验以及一项大型随机安慰剂对照试验。这些报告表明拉莫三嗪可能对双相情感障碍的治疗有效。

结论

尽管目前的数据有限,但难治性双相情感障碍患者可能从拉莫三嗪治疗中获益。目前正在进行多项研究以确定拉莫三嗪在双相情感障碍治疗中的适当作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验